ReDS Pulmonary Congestion Monitoring Technology will be Showcased at Upcoming Arab Health Exhibition NETANYA, Israel, June 8, 2021 /PRNewswire/ — Sensible Medical Innovations, the market leader in medical radar monitoring and imaging technology (ReDS™) has signed a partnership with Heart Beat Medical, Dubai, UAE – a leading medical device distributor. This agreement will enable hundreds of thousands of patients, […]
Tag: ReDS
Medicure Announces SMILE™-HF Study Demonstrates Use of ReDS™ Results in 58% Reduction in Hospital Readmission Rate
WINNIPEG, Oct. 15, 2019 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to announce the primary results of the late-breaking SMILETM-Heart Failure (SMILE-HF) Clinical Trial which was presented at the recent Heart Failure Society of America (“HFSA”) conference in Philadelphia, PA by Dr. William T. Abraham, the SMILE-HF national principal investigator. The […]
Medicure Announces Launch of New and Improved ReDS™ PRO
WINNIPEG, Sept. 17, 2019 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to announce the launch of the ReDSTM PRO (“ReDSTM PRO”) system, the next generation of lung fluid management technology for heart failure. The debut of the new system took place at the recent Heart Failure Society of America (“HFSA”) […]
Sensible Medical announces ReDS™ Pro, the next generation of market leading lung fluid management technology for heart failure
Non-invasive monitoring technology assists in managing heart failure patients TENAFLY, N.J., Sept. 14, 2019 /PRNewswire/ — Sensible Medical Innovations today announced the launch of the ReDSTM PRO system. The debut of the new system was at the Heart Failure society of America conference in Philadelphia, PA. ReDSTM PRO is optimized for the Point-of-Care, designed for use in hospitals and sub-acute facilities. ReDSTM PRO […]
Medicure Announces Agreement to Market ReDS™ Device for Congestive Heart Failure Patients in the United States
WINNIPEG, Jan. 28, 2019 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company“) (TSXV:MPH,OTC: MCUJF), a cardiovascular pharmaceutical company, is pleased to announce it has entered into an agreement with Sensible Medical Innovations Inc. (“Sensible”) to become the exclusive marketing partner for the ReDS™ point of care system (“ReDS”) in the United States. ReDS is a non-invasive, FDA-cleared medical device […]